JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB168341

Anti-Galactosidase alpha antibody [EP5828(2)]

5

(2 리뷰들)

|

(16 제품이 사용된 논문 )

Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) is a rabbit monoclonal antibody detecting Galactosidase alpha in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications

대체 명칭 보기

Alpha-galactosidase A, Alpha-D-galactosidase A, Alpha-D-galactoside galactohydrolase, Galactosylgalactosylglucosylceramidase GLA, Melibiase, GLA

10 이미지
Flow Cytometry (Intracellular) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Intracellular Flow Cytometry analysis ofHeLa cells labelling Galactosidase alpha with purified ab168341 at a dilution of 1/90 (red). Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. An Alexa Flour® 488-conjugated goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human urinary bladder carcinoma tissue labelling Galactosidase alpha with unpurified ab168341 at a dilution of 1/50.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human uterus tissue labelling Galactosidase alpha with unpurified ab168341 at a dilution of 1/50.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue labelling Galactosidase alpha with purified ab168341 at 1/50. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

Immunoprecipitation - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • IP

Lab

Immunoprecipitation - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

ab168341 (purified) at 1/60 immunoprecipitating Galactosidase alpha in MCF-7 whole cell lysate.

Lane 1 (input) : MCF-7 whole cell lysate (10μg)

Lane 2 (+) : ab168341 + MCF-7 whole cell lysate.

Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab168341 in MCF-7 whole cell lysate.

For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341)

Predicted band size: 49 kDa

Observed band size: 46 kDa

false

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • WB

Lab

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Lanes 1-2 : Merged signal (red and green). Green - ab168341 observed at 49 kDa. Red - loading control ab8245 observed at 37 kDa.

ab168341 Anti-Galactosidase alpha antibody [EP5828(2)] was shown to specifically react with Galactosidase alpha in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265563 (knockout cell lysate ab257449) was used. Wild-type and Galactosidase alpha knockout samples were subjected to SDS-PAGE. ab168341 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

GLA knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human GLA (Galactosidase alpha) knockout HeLa cell line (<a href='/ko/products/cell-lines/human-gla-galactosidase-alpha-knockout-hela-cell-line-ab265563'>ab265563</a>)

Predicted band size: 38 kDa,49 kDa

Observed band size: 49 kDa

false

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • WB

Lab

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) at 1/5000 dilution

All lanes:

HEK293 whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 49 kDa

Observed band size: 46 kDa

false

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • WB

Lab

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Lanes 1 - 4 : Merged signal (red and green). Green - ab168341 observed at 49 kDa. Red - loading control, ab130007, observed at 125 kDa.

ab168341 was shown to recognize GLA (Alpha-galactosidase A) in wild-type HAP1 cells as signal was lost at the expected MW in GLA knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and GLA knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% milk. ab168341 and ab130007 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) at 1/1000 dilution

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

GLA knockout HAP1 whole cell lysate at 20 µg

Lane 3:

Hela whole cell lysate at 20 µg

Lane 4:

MCF-7 whole cell lysate at 20 µg

Predicted band size: 49 kDa

false

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • WB

Lab

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) at 20 µg

All lanes:

MCF-7 whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 49 kDa

Observed band size: 46 kDa

false

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)
  • WB

Unknown

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (AB168341)

All lanes:

Western blot - Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) at 1/1000 dilution

Lane 1:

MCF-7 cell lysates at 10 µg

Lane 2:

293T cell lysates at 10 µg

Lane 3:

A431 cell lysates at 10 µg

Lane 4:

HeLa cell lysates at 10 µg

Predicted band size: 49 kDa

false

관련 conjugated 항체와 다양한 조성의 항체 (9)

  • Carrier free

    Anti-Galactosidase alpha antibody [EP5828(2)] - BSA and Azide free

  • 660 APC

    APC Anti-Galactosidase alpha antibody [EP5828(2)]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Galactosidase alpha antibody [EP5828(2)]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Galactosidase alpha antibody [EP5828(2)]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-Galactosidase alpha antibody [EP5828(2)]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Galactosidase alpha antibody [EP5828(2)]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Galactosidase alpha antibody [EP5828(2)]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-Galactosidase alpha antibody [EP5828(2)]

  • 578 PE

    PE Anti-Galactosidase alpha antibody [EP5828(2)]

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP5828(2)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, Flow Cyt (Intra), WB, ICC/IF, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/90", "FlowCytIntra-species-notes": "<p></p>" } } }

제품 세부 정보

What is this antibody validated in?
Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of Galactosidase alpha?
Anti-Galactosidase alpha [EP5828(2)] (ab168341) specifically detects a band for Galactosidase alpha (UniProt: P06280) at a molecular weight of 49kDa.

Trusted by the scientific community
Anti-Galactosidase alpha [EP5828(2)] (ab168341) was first used in a scientific publication in 2013 and has been cited over 10 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-Galactosidase alpha antibody [EP5828(2)] (ab168341) has been confirmed by Western blot testing in GLA Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EP5828(2)] also available for your convenience: ab168341, Carrier free - ab215258, APC - ab310830, PE - ab310906, Alexa Fluor® 488 - ab310964, Alexa Fluor® 647 - ab311082, Alexa Fluor® 594 - ab311676, Alexa Fluor® 568 - ab312951, Alexa Fluor® 555 - ab313160, Alexa Fluor® 750 - ab321155

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Alpha-galactosidase also known as alpha-D-galactosidase or A-galactosidase is an enzyme that catalyzes the hydrolysis of terminal alpha-galactosyl moieties from glycolipids and glycoproteins. It has a molecular mass of approximately 50000 Daltons. This enzyme is expressed in various tissues including the liver heart and kidneys. It functions by efficiently removing alpha-galactose residues from target molecules a process important for maintaining cellular function.
Biological function summary

The role of alpha-galactosidase involves the breakdown of complex carbohydrates particularly those containing alpha-galactosidic bonds. It does not operate as part of a complex but rather functions independently to cleave these specific bonds in glycolipids and glycoproteins. This activity is critical for degrading langerin and other gangliosides preventing the accumulation of these molecules in the lysosomes. By continuously performing this function alpha-galactosidase maintains glycosphingolipid homeostasis ensuring efficient cellular metabolism.

Pathways

The involvement of alpha-galactosidase in metabolic and lysosomal catabolic pathways is significant. One critical pathway is the glycolipid metabolism pathway where it acts alongside related enzymes such as beta-galactosidase. It also participates in the lysosomal degradation pathway working in conjunction with other lysosomal enzymes to prevent substrate buildup. The interaction with enzymes like lysosomal hydrolases ensures the proper breakdown of complex molecules into simpler ones that cells can utilize or excrete.

Defects in the alpha-galactosidase enzyme lead to the lysosomal storage disorder known as Fabry disease. This genetic disorder causes the accumulation of globotriaosylceramide due to deficient alpha-galactosidase activity. Another disorder associated with malfunctioning alpha-galactosidase is cardiac complications due to tissue storage of glycolipids. In both cases the lack of enzyme activity disrupts cellular and tissue functions linking alpha-galactosidase to clinical symptoms seen in these disorders.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Catalyzes the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome.
See full target information GLA

제품이 사용된 논문 (16)

Recent publications for all applications. Explore the 전체 목록 and refine your search

International journal of molecular sciences 26: PubMed40332602

2025

Establishment of a Human iPSC Line from Mucolipidosis Type II That Expresses the Key Markers of the Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Maria Eduarda Moutinho,Mariana Gonçalves,Ana Joana Duarte,Marisa Encarnação,Maria Francisca Coutinho,Liliana Matos,Juliana Inês Santos,Diogo Ribeiro,Olga Amaral,Paulo Gaspar,Sandra Alves,Luciana Vaz Moreira

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38:845-854 PubMed39343861

2024

Biochemical Amenability in Fabry Patients Under Chaperone Therapy-How and When to Test?

Applications

Unspecified application

Species

Unspecified reactive species

Malte Lenders,Elise Raphaela Menke,Eva Brand

Nature communications 15:2553 PubMed38519472

2024

SNX8 enables lysosome reformation and reverses lysosomal storage disorder.

Applications

Unspecified application

Species

Unspecified reactive species

Xinran Li,Cong Xiang,Shilei Zhu,Jiansheng Guo,Chang Liu,Ailian Wang,Jin Cao,Yan Lu,Dante Neculai,Pinglong Xu,Xin-Hua Feng

QJM : monthly journal of the Association of Physicians 117:566-573 PubMed38429952

2024

Clinical characteristics and induced pluripotent stem cells (iPSCs) disease model of Fabry disease caused by a novel GLA mutation.

Applications

Unspecified application

Species

Unspecified reactive species

L Gao,Z Lu,Y Zhang,L Liu,J Sun,H Fu,J Mao,L Hu

Orphanet journal of rare diseases 18:275 PubMed37670350

2023

Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease.

Applications

Unspecified application

Species

Unspecified reactive species

Mulan Deng,Hongyu Zhou,Shaomei He,Haoheng Qiu,Yanping Wang,April Yuanyi Zhao,Yunping Mu,Fanghong Li,Allan Zijian Zhao

PeerJ 11:e15125 PubMed37065697

2023

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Xia Niu,Shuyu Zhang,Chen Shao,Zhengguang Guo,Jianqiang Wu,Jianling Tao,Ke Zheng,Wenling Ye,Guangyan Cai,Wei Sun,Mingxi Li

Phytotherapy research : PTR 37:477-489 PubMed36199227

2022

Atractylodin targets GLA to regulate D-mannose metabolism to inhibit osteogenic differentiation of human valve interstitial cells and ameliorate aortic valve calcification.

Applications

Unspecified application

Species

Unspecified reactive species

Linghang Qu,Chunli Wang,Haiying Xu,Lanqing Li,Yanju Liu,Qianyun Wan,Kang Xu

Molecular therapy. Methods & clinical development 26:323-330 PubMed35990747

2022

Pre-existing anti-drug antibodies in Fabry disease show less affinity for pegunigalsidase alfa.

Applications

Unspecified application

Species

Unspecified reactive species

Malte Lenders,Solvey Pollmann,Melina Terlinden,Eva Brand

International journal of molecular sciences 22: PubMed34768768

2021

α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Ulrich Jehn,Samet Bayraktar,Solvey Pollmann,Veerle Van Marck,Thomas Weide,Hermann Pavenstädt,Eva Brand,Malte Lenders

International journal of molecular sciences 22: PubMed33800950

2021

Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Malte Lenders,David Scharnetzki,Ali Heidari,Daniele Di Iorio,Seraphine Valeska Wegner,Eva Brand
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com